UncategorizedAlnylam to invest $250 M in U.S. facility to expand RNAi manufacturing – Longevity.Technology Empower Meds / December 19, 2025
UncategorizedPeptiDream and Alnylam achieve milestone in siRNA conjugate delivery collaboration – Longevity.Technology Empower Meds / December 19, 2025
UncategorizedGlobal blood glucose monitor market projected to reach USD 25.4 billion by 2030 – Longevity.Technology Empower Meds / December 18, 2025
UncategorizedKenai Therapeutics doses first patient in Phase 1 neuron replacement Parkinson’s trial – Longevity.Technology Empower Meds / December 18, 2025
UncategorizedCell therapies poised to unlock a projected $403 billion “cure economy” by 2032 – Longevity.Technology Empower Meds / December 18, 2025
UncategorizedFountain Life partners with Flexjet to bring preventive health services to private jet customers – Longevity.Technology Empower Meds / December 18, 2025
Uncategorized2025’s hottest supplements are in – and one mineral stole the show Empower Meds / December 18, 2025
UncategorizedBeacon Biosignals partners with Harmony Biosciences to add EEG into hypersomnia Phase 3 trials – Longevity.Technology Empower Meds / December 18, 2025
UncategorizedZealand links with China biotech in $20m metabolic discovery deal Empower Meds / December 18, 2025
